Effects of brewed vinegar and red yeast extract as dietary supplement alone and in combination on serum lipids in middle-aged and elderly humans

Journal of Clinical Rehabilitative Tissue Engineering Research

Volumn 11, Issue 39, 2007, Pages 7795-7798

  Geng, Cheng Yan ^a   Jiang, Li Ping ^a   Gong, De Zheng ^a   Liu, J ^a   Wang, D L ^a   Zhou, C Y ^a   Wang, H L ^a   Hu, S R ^a   Zhong, Lai Fu ^a  

^a DALIAN MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; NATURAL PRODUCT; RED YEAST EXTRACT; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; VINEGAR;

ABSENCE OF SIDE EFFECTS; ADULT; AGED; ARTICLE; CHINA; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL INTAKE; CLINICAL ARTICLE; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DIET SUPPLEMENTATION; DIETARY FIBER; DIETARY INTAKE; DRUG CAPSULE; DRUG EFFICACY; ENERGY CONSUMPTION; GLUCOSE BLOOD LEVEL; HUMAN; HYPERTRIGLYCERIDEMIA; KIDNEY FUNCTION; LIPID BLOOD LEVEL; LIVER FUNCTION; MACRONUTRIENT; MIDDLE AGED; MONOTHERAPY; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 36148946377     PISSN: 16738225     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Lamarche B, Lewis GF. Atherosclerosis prevention for the next decade: risk assessment beyond low density lipoprotein cholesterol. Can J Cardiol 1998;14:841-851
2. Cui Y, Blumenthal RS, Flaws JA et al. Non-high-density lipoprotein cholesterol level as a predictor of cardiovascular disease mortality. Arch Intern Med 2001;161:1413-1419
3. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection. Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001;285:2486-2497
4. Nomura E, Kohriyama T, Matsumoto M, et al. Clinical characteristics of first-ever atherothrombotic infarction or lacunar infarction with hyperlipidemia (J-STARS-C):an analysis of data from the stroke data bank of Japan. Intern Med 2005;44:1252-1257
5. Fujino T, Kanaya S, Kali R, et al. Effects of solid components in brew vinegar on human serum lipids. J Health Sci 1993;15:91-93
6. Chinese source.
7. Fushimi T, Suruga K, Oshima Y, et al. Dietary acetic reduces serum cholesterol and triacylglycerols in rats fed a cholesterol-rich diet. Br J Nutr 2006;95(5):916-924
8. Leeman M, Ostman E, Bjorck I, et al. Vinegar dressing and cold storage of potatoes lowers postprandial glycaemic and insulinaemic responses in healthy subjects. Eur J Clin Nutr 2005;59(11):1266-1271
9. Ma J, Li Y, Ye Q, et al. Constituents of red yeast rice, a tranditional Chinese food and medicine. J Agric Food Chem 2000;48:5220-5225
10. Chinese source.
11. Lin CC, Li TC, Lai MM. Efficacy and safety of monascus purpureus went rice in subjects with hyperlipidemia. Eur J Endocrinol 2005;153 (5): 679-686
12. Lee CL, Tsai TY, Wang JJ, et al. In vivo hypolipidemic effects and safety of low dosage Monascus powder in ahamster model of hyperlipidemia. Appl Microbiol Biotechnol 2006;70(5):533-540
13. Chinese source.
14. Setnikar I, Senin P, Rovati LC. Antiatherosclerotic efficacy of policosanol, red yeast rice extract and astaxanthin in the rabbit. Arzneimittelforschung 2005;55(6):312-317
15. Wei W, Li C, Wang Y, et al. Hypolipidemic and anti-atherogenic effects of long-term Cholestin (Monascus purpurus-fermented rice, red yeash rice in cholesterol fed rabbits. J Nutr Biochem 2003;14(6):314-318
16. earson TA. Commentary: lipid-lowering therapy in low-risk patients. JAMA 1998;279:1659-1661
17. Baigent C, Keech A, Kearney PM, et al. Efficacy and safety of cholesterol-lowering treament prospective meta-analysis of datafrom 90, 056 participants in 14 randomised trials of statins. Lancet 2005;366: 1267-1278
18. Endres M. Statins: potential new indications in inflammatory conditions. Atheroscler Suppl 2006; 7:31-35
19. Amarenco P, Labreuche J, Lavallee P, et al. Statins in stroke prevention and carotid atherosclerosis: systematic review and up-to-date meta-analysis. Stroke 2004;35:2902-2909
20. Endo A. Monacolin K, a new hypocholesterolemic agent produced by a Monascus species. J Antibiot (Tokyo) 1979;32(8):852-854